Dietary Inflammatory Index and Objective and Subjective Memory Impairments in Breast Cancer Survivors

Krystle E Zuniga,Julio Fernandez
DOI: https://doi.org/10.1096/fasebj.31.1_supplement.790.36
2017-04-01
The FASEB Journal
Abstract:Background Cancer related cognitive impairment (CRCI) can have significant and persistent impacts on quality of life in cancer survivors. Recent evidence has reported cognitive impairments may be associated with increases in systemic inflammation due to cancer and its treatment. There is an increasing need to determine whether modifiable factors, such as nutrition, may reduce the risk or severity of CRCI. The objective of this study was to determine the relationship between the inflammatory potential of the diet and memory in breast cancer survivors (BCS) and to explore reduced inflammation as a potential mechanism by which diet influences cognitive function. Methods In this cross‐sectional study, sixty‐seven women (29 BCS; 38 controls) were recruited from the Central Texas area. BCS had to have completed primary treatment (either chemotherapy, radiotherapy or both) within the past 5 years, and controls must have had no previous cancer diagnosis. Participants completed the NIH Toolbox Cognition Battery which included the list sorting working memory and picture sequence memory tests. The Functional Assessment of Cancer Therapy‐Cognitive Function, a validated questionnaire, was used to assess perceived cognitive impairment. Dietary Inflammatory Index (DII) was computed from FFQ estimated dietary intakes. Serum levels of soluble TNF receptor type II (sTNF‐RII), interleukin‐6 (IL‐6), and C‐reactive protein (CRP) were measured by ELISA. Differences between BCS and age‐matched controls were assessed using linear mixed models, and linear regression analyses were conducted to determine the relationship between predictors and objective and subjective cognitive function. Results BCS performed similarly to age‐matched controls on memory tasks, but had significantly more cognitive complaints as assessed by Perceived Cognitive Impairments (p <.001), Comments from Others (p = .001) Impact on Quality of Life (p = .003) and Perceived Cognitive Abilities (p <.001) subscales. Serum sTNF‐RII, but not IL‐6 or CRP, was significantly higher in BCS. The inflammatory biomarkers were not significant predictors of objective or subjective cognitive function and were not associated with DII scores. DII did not predict objective memory performance. In BCS, higher DII, indicating a more pro‐inflammatory diet, was associated with significantly more severe impacts of pereceived cognitive impairments on quality of life (p=.035). Conclusion DII was not associated with levels of inflammatory markers or objective cognitive function in BCS. However, future research should continue to identify dietary patterns that can reduce memory complaints and support cognitive health in cancer survivors. Support or Funding Information Texas State University Research Enhancement Program
cell biology,biochemistry & molecular biology,biology
What problem does this paper attempt to address?